Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Marler

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Stroke|April 1, 1988
Comparison of admission serum glucose concentration with neurologic outcome in acute cerebral infarction. A study in patients given naloxoneH P Adams, C P Olinger, J R Marler, et al.
Archives of Neurology|November 1, 1990
Circadian variation in onset of acute ischemic strokeE E Marsh, J Biller, H P Adams, et al.
Annals of Emergency Medicine|November 1, 1988
The investigational use of tPA for strokeT Brott, E C Haley, D E Levy, et al.
Stroke|February 1, 1994
Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic strokeD E Levy, T G Brott, E C Haley, et al.
Neurology|April 23, 2003
Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessmentB M Ravina, S C Fagan, R G Hart, et al.
Stroke|September 1, 1990
Large-dose infusions of heparinoid ORG 10172 in ischemic strokeE W Massey, J Biller, J N Davis, et al.
Stroke|November 5, 1999
Does the National Institutes of Health Stroke Scale favor left hemisphere strokes? NINDS t-PA Stroke Study GroupD Woo, J P Broderick, R U Kothari, et al.
Stroke|May 1, 1990
High-dose intravenous naloxone for the treatment of acute ischemic strokeC P Olinger, H P Adams, T G Brott, et al.
Stroke|July 1, 1989
Measurements of acute cerebral infarction: lesion size by computed tomographyT Brott, J R Marler, C P Olinger, et al.
Stroke|May 11, 1992
Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onsetE C Haley, D E Levy, T G Brott, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Stroke|April 1, 1988
Comparison of admission serum glucose concentration with neurologic outcome in acute cerebral infarction. A study in patients given naloxoneH P Adams, C P Olinger, J R Marler, et al.
Archives of Neurology|November 1, 1990
Circadian variation in onset of acute ischemic strokeE E Marsh, J Biller, H P Adams, et al.
Annals of Emergency Medicine|November 1, 1988
The investigational use of tPA for strokeT Brott, E C Haley, D E Levy, et al.
Stroke|February 1, 1994
Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic strokeD E Levy, T G Brott, E C Haley, et al.
Neurology|April 23, 2003
Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessmentB M Ravina, S C Fagan, R G Hart, et al.
Stroke|September 1, 1990
Large-dose infusions of heparinoid ORG 10172 in ischemic strokeE W Massey, J Biller, J N Davis, et al.
Stroke|November 5, 1999
Does the National Institutes of Health Stroke Scale favor left hemisphere strokes? NINDS t-PA Stroke Study GroupD Woo, J P Broderick, R U Kothari, et al.
Stroke|May 1, 1990
High-dose intravenous naloxone for the treatment of acute ischemic strokeC P Olinger, H P Adams, T G Brott, et al.
Stroke|July 1, 1989
Measurements of acute cerebral infarction: lesion size by computed tomographyT Brott, J R Marler, C P Olinger, et al.
Stroke|May 11, 1992
Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onsetE C Haley, D E Levy, T G Brott, et al.
Pageof 5